Triosephosphate Isomerase Levels in Rheumatoid Arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial studies a substance called triosephosphate isomerase (an enzyme) in the blood of people with rheumatoid arthritis. The goal is to see if its level is linked to how active your RA is and to any joint damage over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with rheumatoid arthritis, as diagnosed by a doctor using standard criteria.
- You do not have other serious health conditions that are not well controlled (like high blood pressure, diabetes, heart, liver, or kidney disease, other autoimmune disorders, or cancer).
- You are not pregnant.
- You do not have any other rheumatologic diseases (such as lupus or gout).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called PTC844 in people with active rheumatoid arthritis (RA) to see if it can reduce joint inflammation and symptoms. It may be an option if you've just been diagnosed or if your current treatment isn't working well.
This study looks at levels of certain immune system proteins (IL-6, IL-12, IL-15, and IL-23) in the blood of people with rheumatoid arthritis. It aims to understand how these proteins relate to the disease and may help guide future treatments for better outcomes.
This trial studies an add-on treatment approach for rheumatoid arthritis (RA) in adults whose symptoms did not improve with standard “first-line” medicines. It may help people who still have active RA after trying certain disease-modifying drugs.
This study is looking at people with rheumatoid arthritis (RA) who also have interstitial lung disease (ILD), a condition that causes scarring in the lungs. It aims to understand how the disease changes over time by using imaging and blood tests, without providing any new treatments right now.
This study looks at a new blood marker called Isthmin-1 to see if it can measure how active your rheumatoid arthritis is. They compare it with ultrasound images of your joints to better understand disease activity.
This study tests an investigational drug called TLL-018 for people with moderate to severe rheumatoid arthritis who have not improved enough with standard disease-modifying drugs. It aims to see if the drug can reduce joint pain and swelling.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.